What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.81%Above 5Y avg (0.69%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
36.5%Sustainable
Payback Period
50.6 yr
Last Ex-Dividend
Jun 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.10BCNY
764.95M · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
20.88x
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Revenue (TTM)
3.83BCNY
574.57M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
6.33%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Beta
0.2270x
vs all stocks
Updated Oct 22, 2026
52-Week Change
-18.83%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
5.10BCNY
764.95M · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
5.92BCNY
887.23M · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
20.88x
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Price to Sales (TTM)
1.38x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.33×.Updated Oct 22, 2026
Price to Book (MRQ)
1.39x
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Enterprise to Revenue
1.54x
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Enterprise to EBITDA
7.10x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.37×.Updated Oct 22, 2026
Gross Margin
29.79%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Profit Margin
6.33%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Operating Margin
14.21%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Return on Assets (TTM)
6.85%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Return on Equity (TTM)
7.07%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Revenue (TTM)
3.83BCNY
574.57M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
6.28CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
2.70%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Gross Profit (TTM)
1.16BCNY
173.94M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
570.97MCNY
85.57M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
242.57MCNY
36.35M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
-25.40%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
331.24MCNY
49.64M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
-22.96MCNY
-3.44M · vs all stocks (USD)
Updated Oct 22, 2026
Trailing Annual Dividend Rate
0.1460CNYUpdated Oct 22, 2026
Trailing Annual Dividend Yield
1.81%
vs all stocks
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.69%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
36.45%
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Minority Interest (Equity)
19.77MCNYFY2025 · Dec 31, 2025
Revenue
3.67BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.62BCNYFY2025 · Dec 31, 2025
Gross Profit
1.05BCNYFY2025 · Dec 31, 2025
Operating Income
594.90MCNY
89.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
309.02MCNYFY2025 · Dec 31, 2025
Income Tax Expense
51.87MCNYFY2025 · Dec 31, 2025
Net Income
257.15MCNYFY2025 · Dec 31, 2025
EBIT
326.69MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
812.92MCNYFY2025 · Dec 31, 2025
Research & Development
104.05MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
122.11MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
33.15MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
16.67MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
17.67MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4022CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4022CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
618.81MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
618.81MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
257.15MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-8.26MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
82.46MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-177.85MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
965.72MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
257.15MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
33.09MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-120.22MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-87.55MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-260.31MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.19BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.18BCNYFY2025 · Dec 31, 2025
Other Investing Activity
3.61MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-266.09MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
594.01MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-637.35MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-52.34MCNYFY2025 · Dec 31, 2025
Other Financing Charges
30.51MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-65.17MCNYFY2025 · Dec 31, 2025
Shares Outstanding
633.27MSharesUpdated Oct 22, 2026
Float Shares
204.17MSharesUpdated Oct 22, 2026
% Held by Insiders
62.43%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
2.35%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
471.75MCNY
70.70M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
0.7670CNYUpdated Oct 22, 2026
Total Debt (MRQ)
1.22BCNY
183.06M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.3280x
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Current Ratio (MRQ)
1.59x
vs Medical Instruments & Supplies peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
6.00CNYUpdated Oct 22, 2026
Total Assets
5.61BCNY
840.35M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.40BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.99BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.20BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
663.12MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.33BCNYFY2025 · Dec 31, 2025
Cash
965.18MCNYFY2025 · Dec 31, 2025
Cash Equivalents
2.44MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
967.62MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
4.56MCNYFY2025 · Dec 31, 2025
Accounts Receivable
517.70MCNYFY2025 · Dec 31, 2025
Inventory
720.30MCNYFY2025 · Dec 31, 2025
Accounts Payable
476.22MCNYFY2025 · Dec 31, 2025
Short-term Debt
634.24MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.21MCNYFY2025 · Dec 31, 2025
Long-term Debt
173.34MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
633.27MCNYFY2025 · Dec 31, 2025
Retained Earnings
2.25BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.61BCNY
541.75M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
148.52MCNYFY2025 · Dec 31, 2025
52-Week Low
8.05CNYUpdated Oct 22, 2026
52-Week High
14.90CNYUpdated Oct 22, 2026
52-Week Change
-18.83%
vs all stocks
Updated Oct 22, 2026
Beta
0.2270x
vs all stocks
Updated Oct 22, 2026
50-Day MA
8.87CNYUpdated Oct 22, 2026
200-Day MA
10.47CNYUpdated Oct 22, 2026
Avg 10-Day Volume
6.74MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
5.75MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
0.4000CNYUpdated Oct 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.17: safe zoneNotable
Altman Z-Score: 3.17
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $574.57M, above the global median of $566.17MNotable